BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $73,927,000 | -19.1% | 489,030 | -22.0% | 0.03% | -18.8% |
| Q2 2022 | $91,368,000 | +27.6% | 627,053 | +3.8% | 0.03% | +45.5% |
| Q1 2022 | $71,596,000 | -8.0% | 603,825 | +6.9% | 0.02% | -4.3% |
| Q4 2021 | $77,845,000 | +1.6% | 564,870 | +2.4% | 0.02% | -8.0% |
| Q3 2021 | $76,623,000 | +97.8% | 551,599 | +38.3% | 0.02% | +92.3% |
| Q2 2021 | $38,731,000 | +53.7% | 398,959 | +8.2% | 0.01% | +44.4% |
| Q1 2021 | $25,195,000 | -14.6% | 368,606 | +7.0% | 0.01% | -25.0% |
| Q4 2020 | $29,514,000 | +33.0% | 344,338 | +0.9% | 0.01% | +20.0% |
| Q3 2020 | $22,188,000 | -4.1% | 341,295 | +7.8% | 0.01% | -9.1% |
| Q2 2020 | $23,148,000 | +136.9% | 316,611 | +10.3% | 0.01% | +83.3% |
| Q1 2020 | $9,770,000 | -30.3% | 287,081 | +11.5% | 0.01% | -25.0% |
| Q4 2019 | $14,012,000 | +28.1% | 257,384 | -1.9% | 0.01% | +33.3% |
| Q3 2019 | $10,942,000 | +12.6% | 262,253 | +18.2% | 0.01% | 0.0% |
| Q2 2019 | $9,716,000 | -2.7% | 221,864 | +14.4% | 0.01% | 0.0% |
| Q1 2019 | $9,984,000 | +52.2% | 193,961 | +9.4% | 0.01% | +20.0% |
| Q4 2018 | $6,558,000 | +10.5% | 177,332 | +12.2% | 0.01% | +25.0% |
| Q3 2018 | $5,934,000 | +8.2% | 158,009 | +13.9% | 0.00% | 0.0% |
| Q2 2018 | $5,484,000 | +142.9% | 138,755 | +58.3% | 0.00% | +100.0% |
| Q1 2018 | $2,258,000 | +108.5% | 87,642 | +118.4% | 0.00% | +100.0% |
| Q4 2017 | $1,083,000 | -24.3% | 40,137 | +4.9% | 0.00% | 0.0% |
| Q3 2017 | $1,431,000 | +57.4% | 38,265 | +5.3% | 0.00% | 0.0% |
| Q2 2017 | $909,000 | – | 36,332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |